Börse:
2,206€
0,85%
Echtzeit-Aktienkurs Agenus
Bid:
2,176€
Ask:
2,237€
| Allgemeine Informationen | ||
|---|---|---|
| Börsenwert: | 264,74 Mio. EUR (120,00 Mio. x 2,206€) | |
| Website: | - | |
| Sektor: | Medizin / Biotechnologie | |
| News-Radar | |
|---|---|
| dpa-AFX Pro - | Newsbot 1 |
| dpa-AFX - | Reuters - |
| 2015 | 2016 | 2017 | 2018 | |
|---|---|---|---|---|
| KUV | 7,68 | 8,58 | 5,23 | 7,20 |
| KGV | - | - | - | - |
| Div. Rend. | - | - | - | - |
Echtzeit-Chart der Agenus Aktie
Börsenkurse Agenus
| Börse Stuttgart | 2,135€ | 10000 | 2,278€ | 10000 | 2,206€ | 1,09% |
| Lang & Schwarz | 2,179€ | 11366 | 2,234€ | 11366 | 2,207€ | -1,45% |
| Euro Indikation | 2,176€ | 0 | 2,237€ | 0 | 2,206€ | 0,85% |
| Dollar Indikation | 2,443$ | 0 | 2,506$ | 0 | 2,475$ | -2,19% |
| Tradegate | 2,176€ | 4600 | 2,237€ | 4500 | 2,206€ | -0,69% |
Fundamentaldaten der Agenus Aktie
Aktuelle Geschäftsentwicklung
Sie benötigen die TraderFox Börsensoftware, um die aktuelle Geschäftsentwicklung einsehen zu können.
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2018 | 36,78 Mio. | -162,04 Mio. | -159,69 Mio. | -1,44 | 0,00% | - | 7,20 |
| 2017 | 42,88 Mio. | -120,69 Mio. | -120,69 Mio. | -1,23 | 0,00% | - | 5,23 |
| 2016 | 22,57 Mio. | -127,00 Mio. | -127,00 Mio. | -1,46 | 0,00% | - | 8,58 |
| 2015 | 24,82 Mio. | -93,27 Mio. | -87,88 Mio. | -1,13 | 0,00% | - | 7,68 |
| 2014 | 6,98 Mio. | -42,49 Mio. | -42,49 Mio. | -0,71 | 0,00% | - | 19,83 |
Profil der Agenus Aktie
Agenus, Inc. is a biotechnology company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its core technology portfolio consists of Saponin platform and Heat Shock Protein platform. The company was founded by Garo H. Armen and Pramod K. Srivastava in March 1994 and is headquartered in Lexington, MA.Anlagetrends zur Agenus Aktie
Trends
TraderFox GmbH:
Impressum & Datenschutz -
Allgemeine Geschäftsbedingungen